Skip to main content
    B

    Bruker Corporation (BRKR)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $60.62
    -0.97 (-1.57%)

    Market Cap: $9.41B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Bruker Corporation (BRKR) Financials: Revenue, Profit and Cash Flow

    Updated Nov 4, 2026. Financial statements from company filings, amounts in US dollars.

    Bruker reported revenue of $3.44B for the fiscal year ended Dec 31, 2025, up 2.1% from the year before. That year, net income was -$8.30M with a net margin of -0.2%, operating cash flow was $134.10M and free cash flow was $43.30M. The quarter ended Sep 30, 2026 had revenue of $874.00M and net income of -$109.70M.

    Revenue and Margins

    The operating margin was 2.0% in the fiscal year ended Dec 2025, the lowest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $1.61B, a compound annual rate of 8.8%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$3.44B+2.1%45.9%2.0%-0.2%
    Dec 2024$3.37B+13.6%49.0%7.5%3.4%
    Dec 2023$2.96B+17.1%51.0%14.7%14.5%
    Dec 2022$2.53B+4.7%51.6%17.1%11.8%
    Dec 2021$2.42B+21.7%50.0%17.1%11.6%
    Dec 2020$1.99B-52.1%47.3%12.5%8.1%
    Dec 2019$4.15B+118.7%24.0%7.3%4.8%
    Dec 2018$1.90B+7.3%47.5%13.8%9.5%
    Dec 2017$1.77B+9.6%46.2%12.4%4.5%
    Dec 2016$1.61BN/A46.3%11.3%9.6%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the company posted a net loss after a profit the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$3.44B$3.37B$2.96B$2.53B$2.42B$1.99B$4.15B$1.90B$1.77B$1.61B
    Cost of revenue$1.86B$1.72B$1.45B$1.23B$1.21B$1.05B$2.15B$995.60M$949.90M$866.00M
    Gross profit$1.58B$1.65B$1.51B$1.31B$1.21B$939.80M$995.30M$900.00M$816.00M$745.30M
    Research and development$395.20M$376.50M$294.80M$235.90M$220.80M$198.00M$187.70M$173.40M$161.60M$147.90M
    Operating income$68.20M$253.10M$436.90M$432.70M$413.30M$248.30M$300.90M$262.40M$219.50M$181.80M
    Net income-$8.30M$113.80M$428.50M$298.50M$280.60M$161.40M$198.00M$181.00M$80.30M$154.50M
    EBITDA$242.30M$390.70M$659.10M$502.70M$482.70M$306.20M$356.00M$309.60M$261.70M$231.90M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$874.00M$838.50M$823.40M$977.20M$860.50M$797.40M$801.40M$979.60M$864.40M$800.70M$721.70M$854.50M
    Gross profit$429.30M$416.00M$379.80M$449.20M$379.40M$357.90M$391.20M$493.30M$418.80M$384.60M$352.80M$430.30M
    Operating income-$91.00M-$65.30M$10.20M$76.30M-$51.80M$11.90M$31.80M$72.10M$68.10M$48.10M$64.80M$103.50M
    Net income-$109.70M-$50.90M$15.70M$29.20M-$58.50M$4.20M$16.80M$13.90M$40.30M$7.60M$52.00M$204.60M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $1.87B exceeded cash and equivalents by $1.57B.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$6.24B$5.81B$4.25B$3.61B$3.65B$3.05B$2.77B$2.13B$1.95B$1.81B
    Current assets$2.21B$2.05B$2.16B$2.11B$2.47B$1.93B$1.80B$1.30B$1.36B$1.28B
    Cash and equivalents$298.80M$183.40M$488.30M$645.50M$1.07B$681.80M$678.30M$322.40M$325.00M$342.40M
    Total liabilities$3.73B$3.99B$2.84B$2.48B$2.57B$2.07B$1.83B$1.20B$1.22B$1.12B
    Short-term debt$16.60M$32.50M$121.20M$18.70M$112.40M$2.20M$500.00K$18.50M$415.60M$20.10M
    Long-term debt$1.85B$2.06B$1.16B$1.20B$1.22B$842.30M$812.80M$322.60M$415.60M$391.60M
    Shareholder equity$0$1.78B$1.38B$1.11B$1.07B$961.20M$906.80M$896.60M$725.40M$686.40M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$5.83B$6.05B$6.13B$6.24B$6.43B$6.34B$5.93B$5.81B$6.11B$5.90B$4.51B$4.25B
    Total liabilities$3.49B$3.62B$3.63B$3.73B$3.94B$4.47B$4.08B$3.99B$4.27B$4.08B$3.06B$2.84B
    Cash and equivalents$119.70M$184.90M$133.40M$298.80M$293.10M$92.00M$184.20M$183.40M$148.10M$169.70M$340.10M$488.30M
    Shareholder equity$0$0$0$2.46B$2.43B$0$0$1.78B$1.81B$1.79B$1.42B$1.38B
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 32.3% of operating cash flow. Dividends and share repurchases together came to 99.1% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$134.10M$251.30M$350.10M$274.40M$282.40M$332.20M$213.40M$239.70M$154.40M$130.80M
    Capital expenditures$90.80M$115.30M$106.90M$129.20M$92.00M$97.20M$73.00M$49.20M$43.70M$37.10M
    Free cash flow$43.30M$136.00M$243.20M$145.20M$190.40M$235.00M$140.40M$190.50M$110.70M$93.70M
    Dividends paid$32.90M$30.20M$29.40M$41.60M$24.20M$25.80M$25.00M$26.00M$26.40M$26.50M
    Share repurchases$10.00M$0$152.30M$263.10M$153.30M$123.20M$142.30M$0$152.20M$160.00M
    Investing cash flow-$196.50M-$1.76B-$326.00M-$251.60M-$192.40M-$192.70M-$158.40M-$123.40M-$30.20M-$21.80M
    Financing cash flow$135.10M$1.23B-$193.40M-$415.30M$318.70M-$161.60M$300.00M-$112.40M-$159.00M-$27.90M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$118.20M-$77.40M$71.20M$229.80M-$33.20M-$127.50M$65.00M$190.00M$38.40M$1.10M$21.80M$205.50M
    Capital expenditures$21.50M$28.80M$24.20M$22.60M$20.90M$21.30M$26.00M$36.70M$32.60M$24.60M$21.40M$31.50M
    Free cash flow$96.70M-$106.20M$47.00M$207.20M-$54.10M-$148.80M$39.00M$153.30M$5.80M-$23.50M$400.00K$174.00M
    Last 12 quarters

    Frequently Asked Questions About BRKR

    What is Bruker's annual revenue?

    Bruker reported revenue of $3.44B for the fiscal year ended Dec 31, 2025.

    How fast is Bruker's revenue growing?

    Revenue was up 2.1% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 10.7%.

    Is Bruker profitable?

    No. Bruker reported net income of -$8.30M for the fiscal year ended Dec 31, 2025, with a net margin of -0.2%.

    How much free cash flow does BRKR generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $134.10M minus capital expenditures of $90.80M produced free cash flow of $43.30M.

    How much debt does Bruker have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $1.85B, short-term debt of $16.60M and cash and equivalents of $298.80M.